XML 25 R12.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Fair Value Measurements | 9 Months Ended
--- | ---
Sep. 29, 2018
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 29, 2018:
(in millions) | Level 1 |  | Level 2 |  | Total
Assets: |  |  |  |  |
Short-term investments in marketable securities | $ | 0.8 |  |  | $ | — |  |  | $ | 0.8 |
Restricted cash | 9.5 |  |  | — |  |  | 9.5 |
Derivatives | — |  |  | 5.9 |  |  | 5.9 |
Total assets | $ | 10.3 |  |  | $ | 5.9 |  |  | $ | 16.2 |
Liabilities: |  |  |  |  |  |  |  |
Derivatives | $ | — |  |  | $ | 5.7 |  |  | $ | 5.7 |
Deferred compensation | 4.2 |  |  | 30.9 |  |  | 35.1 |
Total liabilities at fair value | $ | 4.2 |  |  | $ | 36.6 |  |  | $ | 40.8 |
Liabilities measured at net asset value |  |  |  |  | 11.0 |
Total liabilities |  |  |  |  | $ | 51.8 |
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2017:
(in millions) | Level 1 |  | Level 2 |  | Total
Assets: |  |  |  |  |
Cash equivalents | $ | 34.4 |  |  | $ | — |  |  | $ | 34.4 |
Short-term investments in marketable securities | 0.8 |  |  | — |  |  | 0.8 |
Restricted cash | 9.4 |  |  | — |  |  | 9.4 |
Derivatives | — |  |  | 6.0 |  |  | 6.0 |
Total assets | $ | 44.6 |  |  | $ | 6.0 |  |  | $ | 50.6 |
Liabilities: |  |  |  |  |  |  |  |
Derivatives | $ | — |  |  | $ | 7.7 |  |  | $ | 7.7 |
Deferred compensation | 4.0 |  |  | 30.1 |  |  | 34.1 |
Total liabilities at fair value | $ | 4.0 |  |  | $ | 37.8 |  |  | $ | 41.8 |
Liabilities measured at net asset value |  |  |  |  | 11.8 |
Total liabilities |  |  |  |  | $ | 53.6 |
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2017:
(in millions) | Level 1 |  | Level 2 |  | Total
Assets: |  |  |  |  |
Cash equivalents | $ | 0.4 |  |  | $ | 34.0 |  |  | $ | 34.4 |
Short-term investments in marketable securities | 0.8 |  |  | — |  |  | 0.8 |
Restricted cash | 10.7 |  |  | — |  |  | 10.7 |
Derivatives | — |  |  | 7.2 |  |  | 7.2 |
Total assets | $ | 11.9 |  |  | $ | 41.2 |  |  | $ | 53.1 |
Liabilities: |  |  |  |  |  |  |  |
Derivatives | $ | — |  |  | $ | 13.1 |  |  | $ | 13.1 |
Deferred compensation | 4.0 |  |  | 28.4 |  |  | 32.4 |
Total liabilities at fair value | $ | 4.0 |  |  | $ | 41.5 |  |  | $ | 45.5 |
Liabilities measured at net asset value |  |  |  |  | 11.2 |
Total liabilities |  |  |  |  | $ | 56.7 |
In addition to the items shown in the tables above, refer to Note 17 in the Notes to Consolidated Financial Statements in the 2017 Form 10-K for further discussion regarding the fair value measurements associated with the Company’s postretirement benefit plans.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration